Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Unveiling the Future of Global CX; MCI Acquires Market Force Information, a Customer Experience Services Powerhouse
-
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
-
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
-
Equipment Leasing and Finance Association’s Survey of Economic Activity: Monthly Leasing and Finance Index
-
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
-
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
-
Liberty Military Housing Earns Tenth Consecutive Resident Satisfaction Honors
-
Notice to convene the annual general meeting in FirstFarms A/S
-
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
-
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
-
Novo Nordisk A/S - share repurchase programme
-
Ideanomics Announces Fourth-Quarter and Full-Year 2023 Earnings Call Details
-
Dominica reaches monumental agreement with other Caribbean Citizenship by Investment nations
-
MetasTx LLC Celebrates Dr. David Crich’s Achievement of the 2024 James Flack Norris Award in Physical Organic Chemistry
-
Crown Castle Issues Open Letter to Shareholders
-
AMC Networks Commences Tender Offer for Any and All Senior Notes due 2025
-
AMC Networks Inc. Announces Proposed Private Offering of $700 Million of Senior Secured Notes due 2029
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
St Kitts and Nevis leads the regional agreement on Citizenship by Investment regulations
-
Aecon schedules first quarter 2024 financial results release and conference call
-
Captivision Announces New Global Leadership
-
Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results
-
Aqua-Tots Swim School Invites Sterling Community To Celebrate Grand Opening With Swim-sational Extravaganza
-
Blackwells Capital: Nelson Peltz is Not the Change Disney’s Board Needs
-
Hallador Energy Company Announces the Appointment of Marjorie Hargrave as Chief Financial Officer
-
TILT Holdings Crowned a NECANN Cup Winner Third Year in a Row
-
Dyne Therapeutics Announces CEO Transition
-
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
-
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
-
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
-
Intermap Announces $1 Million Program in Malaysia and Business Updates
-
Hydreight Partners with American Frontline Nurses with a Network of Over 26,000 Nurses
-
SIGA Names Larry Miller General Counsel
-
Coherent Announces Optical Circuit Switch for Data Centers
-
Bombardier’s Global 7500 Jet Sets More Than 30 Speed Records, as Precedent-Setting Program Operates Flawlessly Around the World
-
BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rare natural history study of patients living with inherited retinal diseases
-
Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)
-
ProfitRocket AI Announces Relaunch, Presale, and Airdrop Following An Epic Overhaul
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC] - 22 03 2024 - (CGWL)
-
At the Yacht Club de Monaco yachts become ‘smarter’
-
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
-
Rabbi Marvin Hier, Founder and Dean Emeritus of the Simon Wiesenthal Center and Museum of Tolerance, Issues Statement Regarding Nelson Peltz
-
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress
-
Western Metallica Provides Update on Planned Drilling Program at the Caña Brava Project
-
Regeneron Provides Update on Biologics License Application for Odronextamab
-
ThreeD Capital Inc. Announces New YouTube Channel
-
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
-
Agriculture Supply Chain Enterprise Technology Leader Regrow Earns B Corp Certification
-
BioXcel Therapeutics Announces $25 Million Registered Direct Offering
-
Nurix Therapeutics is Part of a Team of International Oncology Experts Selected as Cancer Grand Challenges Awardees to Address Pediatric Cancers Using Targeted Protein Degradation (TPD)
